---
title: "Aileron Therap (ALRN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ALRN.US.md"
symbol: "ALRN.US"
name: "Aileron Therap"
industry: "Biotechnology"
---

# Aileron Therap (ALRN.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

Aileron Therapeutics, Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company’s lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment ...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.11 |

## References

- [Company Overview](https://longbridge.com/en/quote/ALRN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ALRN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ALRN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.